Beta-blockers for prevention and treatment of retinopathy of prematurity in preterm infants.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Cochrane Database of Systematic Reviews

• Publication date

  2015-09-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/14651858.CD011893.pub2PMID 29499081PMCID PMC6494413
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bayley Scales of Infant and Toddler Development

  2017influential reference
• The Efficacy of Propranolol in Retinopathy of Prematurity and its Correlation with the Platelet Mass Index

  2017cited by this paper
• Prophylactic propranolol for prevention of ROP and visual outcome at 1 year (PreROP trial)

  2017cited by this paper
• Propranolol 0.1% eye micro-drops in newborns with retinopathy of prematurity: a pilot clinical trial

  2017cited by this paper
• Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.

  2016cited by this paper
• Oral propranolol in early stages of retinopathy of prematurity

  2016cited by this paper
• Infantile Hemangiomas, Retinopathy of Prematurity and Cancer: A Common Pathogenetic Role of the β‐Adrenergic System

  2015cited by this paper
• A randomized, controlled trial of oral propranolol in infantile hemangioma.

  2015cited by this paper
• Oral Propranolol: A New Treatment for Infants with Retinopathy of Prematurity?

  2015cited by this paper
• A Randomized, Controlled Trial of Oral Propranolol for Infantile Hemangioma

  2015cited by this paper
• The β-adrenergic system as a possible new target for pharmacologic treatment of neovascular retinal diseases.

  2014cited by this paper
• Pharmacokinetics and local safety profile of propranolol eye drops in rabbits

  2014cited by this paper
• Atenolol versus propranolol for the treatment of infantile hemangiomas: a randomized controlled study.

  2014cited by this paper
• The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge

  2014cited by this paper
• Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010

  2013cited by this paper
• Treatment of retinopathy of prematurity: a review of conventional and promising new therapeutic options.

  2013cited by this paper
• Oral propranolol for retinopathy of prematurity: risks, safety concerns, and perspectives.

  2013cited by this paper
• Retinopathy of prematurity

  2013cited by this paper
• Eye drop propranolol administration promotes the recovery of oxygen-induced retinopathy in mice.

  2013cited by this paper
• Initiation and Use of Propranolol for Infantile Hemangioma: Report of a Consensus Conference

  2013cited by this paper
• Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. The Cochrane Collaboration

  2013cited by this paper
• Dangers of propranolol in preterm infants

  2013cited by this paper
• A psychometric study of the Bayley Scales of Infant and Toddler Development - 3rd Edition for term and preterm Taiwanese infants.

  2013cited by this paper
• Oral propranolol versus placebo for retinopathy of prematurity: a pilot, randomised, double-blind prospective study

  2013cited by this paper
• Adverse effects of propranolol when used in the treatment of hemangiomas: A case series of 28 infants

  2012cited by this paper
• Propranolol inhibition of β-adrenergic receptor does not suppress pathologic neovascularization in oxygen-induced retinopathy.

  2012cited by this paper
• Timolol Maleate 0.5% or 0.1% Gel‐Forming Solution for Infantile Hemangiomas: A Retrospective, Multicenter, Cohort Study

  2012cited by this paper
• Adverse effects of propranolol when used in the treatment of hemangiomas: a case series of 28 infants.

  2011cited by this paper
• GRADE guidelines: 8. Rating the quality of evidence--indirectness.

  2011cited by this paper
• GRADE guidelines: 7. Rating the quality of evidence--inconsistency.

  2011cited by this paper
• GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables.

  2011cited by this paper
• Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration

  2011cited by this paper
• Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade.

  2011cited by this paper
• GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias).

  2011cited by this paper
• Antiangiogenic effects of β2‐adrenergic receptor blockade in a mouse model of oxygen‐induced retinopathy

  2011cited by this paper
• GRADE guidelines 6. Rating the quality of evidence--imprecision.

  2011cited by this paper
• On the use of antiangiogenetic medications for retinopathy of prematurity

  2011cited by this paper
• Severe Hypoglycemia During Successful Treatment of Diffuse Hemangiomatosis with Propranolol

  2010cited by this paper
• Hyperkalemia Complicating Propranolol Treatment of an Infantile Hemangioma

  2010cited by this paper
• Effects of β-blockers on glucose and lipid metabolism

  2010influential reference
• Propranolol for infantile hemangiomas: a preliminary report on efficacy and safety in very low birth weight infants.

  2010cited by this paper
• Propranolol for complicated infantile haemangiomas: a case series of 30 infants

  2010cited by this paper
• Infantile Hemangiomas and Retinopathy of Prematurity: Possible Association

  2009cited by this paper
• Neurodevelopmental Outcome of Extremely Low Birth Weight Infants from the Vermont Oxford Network: 1998–2003

  2009cited by this paper
• Propranolol for Severe Infantile Hemangiomas: Follow-Up Report

  2009cited by this paper
• Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control.

  2008influential reference
• Propranolol for severe hemangiomas of infancy.

  2008cited by this paper
• Mid- and long-term outcome of extremely low birth weight (ELBW) infants: An analysis of prognostic factors

  2007cited by this paper
• Retinal and choroidal microangiopathies: therapeutic opportunities.

  2007cited by this paper
• Postnatal Head Growth Deficit Among Premature Infants Parallels Retinopathy of Prematurity and Insulin-like Growth Factor-1 Deficit

  2006cited by this paper
• Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity.

  2006cited by this paper
• The International Classification of Retinopathy of Prematurity revisited.

  2005cited by this paper
• Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial.

  2004cited by this paper
• Are 1-2 tablets dangerous? Beta-blocker exposure in toddlers.

  2004cited by this paper
• Preliminary results of treatment of eyes with high-risk prethreshold retinopathy of prematurity in the early treatment for retinopathy of prematurity randomized trial.

  2003cited by this paper
• Safety, Reliability, and Validity of a Physiologic Definition of Bronchopulmonary Dysplasia

  2003cited by this paper
• Pathogenesis of retinopathy of prematurity.

  2003influential reference
• Bronchopulmonary dysplasia.

  2001cited by this paper
• Peripheral retinal ablation for threshold retinopathy of prematurity in preterm infants.

  1999cited by this paper
• Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor

  1999cited by this paper
• [Retinopathy of prematurity].

  1998cited by this paper
• The biology of vascular endothelial growth factor.

  1997cited by this paper
• Beta-adrenergic receptor blockers. Adverse effects and drug interactions.

  1988influential reference
• Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm.

  1978cited by this paper
• Neonatal Necrotizing Enterocolitis: Therapeutic Decisions Based upon Clinical Staging

  1978cited by this paper
• The Abilities of Babies. A Study in Mental Measurement

  1954influential reference
• Effect of Oxygen on Developing Retinal Vessels with Particular Reference to the Problem of Retrolental Fibroplasia

  1954cited by this paper

• Emerging opportunities in ROP therapy: from inhibiting pathological vessel growth to promoting physiological vascularization

  2026cites this paper
• Retinopathy of prematurity in the era of precision neonatology: from risk stratification to targeted therapies

  2025cites this paper
• A Comprehensive Review: Recent Advances in the Management of Retinopathy of Prematurity (ROP)

  2024cites this paper
• Comparison of Different Doses of Oral and Ocular Propranolol for Retinopathy of Prematurity: A Network Meta-Analysis

  2024cites this paper
• Management of retinopathy of pre-maturity – Beyond the known

  2024cites this paper
• Retinopathy of Prematurity (ROP): From the Perspective of the Neonatologist

  2024cites this paper
• Efficacy and Safety of Prophylactic Agents in Prevention of Retinopathy of Prematurity: A Systematic Review and Meta-analysis of Randomised Controlled Trials

  2024influential citation
• Retinopathy of Prematurity—Targeting Hypoxic and Redox Signaling Pathways

  2024cites this paper
• Genetic variants of the beta-adrenergic receptor pathways as both risk and protective factors for retinopathy of prematurity.

  2024cites this paper
• Primary prevention of ROP: more can be done in all settings

  2023cites this paper
• Interventions to Prevent Bronchopulmonary Dysplasia in Preterm Neonates: An Umbrella Review of Systematic Reviews and Meta-analyses.

  2022cites this paper
• Off Label Use as an Indicator of Therapeutic Need in Pediatrics

  2022cites this paper
• Decoupling Oxygen Tension From Retinal Vascularization as a New Perspective for Management of Retinopathy of Prematurity. New Opportunities From β-adrenoceptors

  2022cites this paper
• New Aspects on the Treatment of Retinopathy of Prematurity: Currently Available Therapies and Emerging Novel Therapeutics

  2022cites this paper
• Analysis of Cochrane Systematic Reviews about retinopathy of prematurity

  2021influential citation
• Clinical Efficacy and Safety of Propranolol in the Prevention and Treatment of Retinopathy of Prematurity: A Meta-Analysis of Randomized Controlled Trials

  2021cites this paper
• Identification of candidate genes and pathways in retinopathy of prematurity by whole exome sequencing of preterm infants enriched in phenotypic extremes

  2021cites this paper
• β3‐Adrenoceptor, a novel player in the round‐trip from neonatal diseases to cancer: Suggestive clues from embryo

  2021cites this paper
• Disability in children and adolescents must be integrated into the global health agenda

  2021cites this paper
• Antenatal exposure to fenoterol is not associated with the development of retinopathy of prematurity in infants born before 32 weeks of gestation

  2020cites this paper
• Reporting of drug trial funding sources and author financial conflicts of interest in Cochrane and non-Cochrane meta-analyses: a cross-sectional study

  2020cites this paper
• Strategies to Prevent Severe Retinopathy of Prematurity: A 2020 Update and Meta-analysis.

  2020cites this paper
• Retinopatía del prematuro: Actualización en detección y tratamiento

  2020cites this paper
• Update in the Treatment of Retinopathy of Prematurity

  2020cites this paper
• Oral propranolol in prevention of severe retinopathy of prematurity: a systematic review and meta-analysis

  2019cites this paper
• Propranolol Attenuates Proangiogenic Activity of Mononuclear Phagocytes: Implication in Choroidal Neovascularization.

  2019cites this paper
• The efficacy and safety of inositol supplementation in preterm infants to prevent retinopathy of prematurity: a systematic review and meta-analysis

  2019cites this paper
• Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity.

  2019cites this paper
• Combination therapy and co-delivery strategies to optimize treatment of posterior segment neurodegenerative diseases.

  2019cites this paper
• Dépistage de la rétinopathie des prématurés chez les grands prématurés : cohorte Epipage 2

  2018cites this paper
• What are the effects of propranolol for prevention of retinopathy of prematurity in preterm infants?

  2018cites this paper
• Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity.

  2016cites this paper
• Propranolol Newborn use only 2019

  year unknowncites this paper